CompaniesSomaxon Pharmaceuticals

Somaxon Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

309

By Phase

PHASE2: 1PHASE2/PHASE3: 1

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
Today
NCT00132119
Hover over trial bars to see details

Recent Trials

NCT00202696Lead Sponsor
Nalmefene Smoking Cessation Study
PHASE2Completed
76 participants
Started: Sep 30, 2005 · Completed: Mar 31, 2006
NCT00132119Lead Sponsor
Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling
PHASE2/PHASE3Completed
233 participants
Started: Aug 31, 2005 · Completed: Aug 31, 2006